Article

Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction.

Dept. of Molecular Pathology and Innovative Therapies, Polytechnic University of Marche, Ancona, Italy.
Atherosclerosis (Impact Factor: 3.97). 05/2009; 206(2):588-93. DOI: 10.1016/j.atherosclerosis.2009.03.034
Source: PubMed

ABSTRACT We performed a cross-sectional study to examine the differences in leukocyte telomere length among three groups of subjects: patients with type 2 diabetes mellitus without history of previous myocardial infarction (Type2DM), patients with type 2 diabetes mellitus with evidence of previous myocardial infarction (Type2DM+MI), and healthy control subjects (CTR). The main objective of the present study is to investigate differences in telomere length between the studied groups of subjects, with the aim to clarify if telomere length could be a reliable marker associated with MI in Type2DM patients. Secondary end point is the identification of associations between leukocyte telomere length and selected variables related to glycemic control, pro-inflammatory status and lipidic profile.
A total of 272 elderly subjects, 103 Type2DM (mean age 70+/-4 years, 59% males), 65 Type2DM+MI (mean age 68+/-7 years, 68% males), and 104 CTR (mean age 69+/-7 years, 50% males) were studied. Telomere length, defined as T/S (Telomere-Single copy gene ratio), was determined in leukocytes by quantitative real-time polymerase chain reaction (real-time PCR)-based assay. Moreover, we assessed: (1) high sensitive C reactive protein (hsCRP), fibrinogen and plasminogen-activator inibitor-1 (PAI-1) as inflammatory markers; (2) fasting glucose, insulin, glycated haemoglobin (HbA1C) and waist-to-hip ratio as markers of glycemic control; (3) total-cholesterol, HDL-cholesterol and triglycerides as markers of lipidic profile, in all sample population. The use of statins and sulfonylurea, as well as the presence of some relevant diabetes complications (nephropathy and retinopathy) were also assessed.
Type2DM+MI elderly patients have leukocyte telomere lengths shorter than those of Type2DM (without MI) and healthy CTR. Moreover, glucose, HbA1C and waist-to-hip ratio, variables related to glycemic control, showed a significant inverse correlation with leukocyte telomeres length.

Full-text

Available from: Francesca Marchegiani, May 29, 2015
1 Follower
 · 
154 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: -Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length (LTL) is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardio-metabolic outcomes in the literature are conflicting. -MEDLINE (1966-present), and EMBASE (1980-present) were last searched on September 9(th) 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. 15 Cohort and 12 case-control studies reporting the association between LTL and stroke, myocardial infarction, and type 2 diabetes were independently selected for inclusion by two reviewers. Data extraction and risk of bias assessment were completed independently by two reviewers using pre-defined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-standard deviation decrease in LTL was significantly associated with stroke (OR=1.21, 95% CI=1.06-1.37; I(2)=61%), myocardial infarction (OR=1.24, 95% CI=1.04-1.47; I(2)=68%), and type 2 diabetes (OR=1.37, 95% CI=1.10-1.72; I(2)=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardio-metabolic outcomes. -Shortened LTL demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity.
    Circulation Cardiovascular Genetics 11/2014; 8(1). DOI:10.1161/CIRCGENETICS.113.000485 · 6.73 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Incident atherothrombotic disease is predicted by leukocyte telomere length, a marker of biological age, and hemostatic factor levels, indicating a hypercoagulable state. We hypothesized that shorter telomeres are associated with elevated circulating levels of hemostatic factors.Methods We examined 171 South African (black) and 182 Caucasian (white) school teachers (mean age±SD 48.5±9.0 years, 50.4% women). Concentrations of fibrinogen, von Willebrand factor antigen (VWF:Ag), D-dimer, and plasminogen activator inhibitor-1 antigen (PAI-1:Ag) were measured in plasma and values log transformed before analysis. Relative average telomere length (T/S ratio) was assessed using multiplex quantitative real-time polymerase chain reaction. Multivariate analyses included demographics, metabolic factors, health behaviour, and medication.ResultsRelative to Caucasians, Africans had shorter mean telomere length (0.82, 95% CI 0.79, 0.86 vs. 1.07, 95% CI 1.04, 1.10) and higher fibrinogen (B=0.085, 95% CI 0.061, 0.109) and PAI-1:Ag (B=0.255, 95% CI 0.206, 0.303) levels, but lower VWF:Ag levels(B=-0.059, 95% CI -0.089, -0.028). Shorter telomeres were associated with higher fibrinogen (B=-0.045, 95% CI -0.088, -0.001), VWF:Ag (B=-0.137, 95% CI -0.193, -0.081), and D-dimer levels (B=-0.201, 95% -0.377, -0.025) conditional on ethnicity. An interaction emerged between ethnicity and telomere length for VWF:Ag, i.e., shorter telomeres were associated with higher VWF:Ag levels in Caucasians (B=-0.170, 95% CI -0.232, -0.108) but not in Africans.Conclusions Shorter telomeres were associated with increased concentrations of several hemostatic factors after adjustment for confounding variables, whereby ethnicity partially moderated this effect. A relation of accelerated biological ageing with hypercoagulability might contribute to the risk of premature atherothrombotic events.This article is protected by copyright. All rights reserved.
    Journal of Thrombosis and Haemostasis 09/2014; 12(12). DOI:10.1111/jth.12733 · 5.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite successful treatment and CD4+ T-cell recovery, HIV-infected individuals often experience a profound immune dysregulation characterized by a persistently low CD4:CD8 T-cell ratio. This residual immune dysregulation is reminiscent of the Immune Risk Phenotype (IRP) previously associated with morbidity and mortality in the uninfected elderly (>85 years). The IRP consists of laboratory markers that include: a low CD4:CD8 T-cell ratio, an expansion of CD8+CD28- T-cells and cytomegalovirus (CMV) seropositivity. Despite the significant overlap in immunological phenotypes between normal aging and HIV infection, the IRP has never been evaluated in HIV-infected individuals. In this pilot study we characterized immune changes associated with the IRP in a sample of successfully treated HIV-infected subjects. 18 virologically suppressed HIV-infected subjects were categorized into 2 groups based on their IRP status; HIV+IRP+, (n = 8) and HIV+IRP-, (n = 10) and compared to 15 age-matched HIV uninfected IRP negative controls. All individuals were assessed for functional and phenotypic immune characteristics including: pro-inflammatory cytokine production, antigen-specific proliferation capacity, replicative senescence, T-cell differentiation and lymphocyte telomere length. Compared to HIV-infected subjects without an IRP, HIV+IRP+ subjects exhibited a higher frequency of TNF-α-producing CD8+ T-cells (p = 0.05) and a reduced proportion of CD8+ naïve T-cells (p = 0.007). The IRP status was also associated with a marked up-regulation of the replicative senescence markers CD57 and KLGR1, on the surface of CD8+T-cells (p = 0.004). Finally, HIV+IRP+ individuals had a significantly shorter mean lymphocyte telomere length than their non-IRP counterparts (p = 0.03). Our findings suggest that, despite similar levels of treatment-mediated viral suppression, the phenotypic and functional immune characteristics of HIV+IRP+ individuals are distinct from those observed in non-IRP individuals. The IRP appears to identify a subset of treated HIV-infected individuals with a higher degree of immune senescence.
    PLoS ONE 02/2015; 10(2):e0117039. DOI:10.1371/journal.pone.0117039 · 3.53 Impact Factor